awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q53430510-FD6BE2DB-4C11-47AF-A42F-055F57C261E8
Q53430510-FD6BE2DB-4C11-47AF-A42F-055F57C261E8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53430510-FD6BE2DB-4C11-47AF-A42F-055F57C261E8
The safety and efficacy of high-dose alefacept compared with a loading dose of alefacept in patients with chronic plaque psoriasis.
P2860
Q53430510-FD6BE2DB-4C11-47AF-A42F-055F57C261E8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53430510-FD6BE2DB-4C11-47AF-A42F-055F57C261E8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8d69f9aa292f6e759379efff14cec93b260a6050
P2860
An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis.